Results 171 to 180 of about 44,840 (262)

Non-invasive treatment of Clostridioides difficile infection with a human-origin probiotic cocktail through gut microbiome-gut metabolome modulations [PDF]

Bijay Gurung, Marı́a C. Courrèges, Julie Pollak, Ramiro Malgor, Lin Jiang, Bo Wang, Shaohua Wang   +6 more
openalex   +1 more source

Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial

, 2022
Stuart H. Cohen, Thomas Louie, Matthew Sims, Elaine E. L. Wang, Aslı Memişoğlu, Barbara McGovern, Lisa Von Moltke   +6 more
openalex   +2 more sources

Clostridioides difficile infection: curbing a difficult menace

Therapeutic Advances in Gastroenterology, 2022
Sahil Khanna, Ryan Pardi
openaire   +2 more sources

The role of Frailty Index Laboratory in predicting clinical outcomes in patients with Clostridioides difficile infections: a 2020–24 single-centre retrospective study [PDF]

Giulia Patti, Nicola Veronese, Nicolò De Gennaro, Elda De Vita, Roberta Papagni, Carmen Pellegrino, Angela Amendolara, Vittorio Guerra, Alessandra Vigna, Vito Spada, M Cormio, D. Cassano, Giuliana Metrangolo, Luigi Ronga, Maria Chironna, Stefania Stolfa, Francesco Di Gennaro, Annalisa Saracino   +17 more
openalex   +1 more source

Clostridioides difficile infection in pediatric inflammatory bowel disease: current understanding and clinical challenges [PDF]

Maria Rogalidou
openalex   +1 more source

2398. Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes [PDF]

, 2019
Travis J Carlson, Bradley T. Endres, Julie Le Pham, Anne J Gonzales-Luna, Faris S. Alnezary, Kimberly Nebo, Julie Miranda, Khurshida Begum, Mohammad Jahangir Alam, Kevin W. Garey   +9 more
openalex   +1 more source

Clostridioides difficile infection in Saudi Arabia: Prevalence, risk factors, and outcomes in a tertiary hospital setting. [PDF]

PLoS One
Aldhaif AM, Al-Garni MA, Muyidi AA, Makkawi MH.   +3 more
europepmc   +1 more source

Clinical Impact of Implementing a Specific Clinical Pathway for the Management of Clostridioides difficile Infection. [PDF]

Infect Dis Ther
Rodríguez-Fernández M, Herrero R, González-De-La-Aleja P, Valverde-Fredet MD, Ventero MP, Trigo-Rodríguez M, Giner L, Aller-García AI, Pinargote-Celorio H, Espíndola-Gómez R, Parra M, Martínez Pérez-Crespo P, Ramos-Rincón JM, Fernández-Pevida A, Lanz-García J, León E, Valiente-De-Santis L, Corzo JE, Rodríguez JC, Merino E, Merchante N.   +20 more
europepmc   +1 more source

Risk Factors and Clinical Impact of Carbapenem-Resistant Enterobacterales Coinfections Among Hospitalized Patients with Clostridioides difficile Infection

, 2022
Lee CC, Chiu CW, Lee JC, Tsai PJ, Ko WC, Hung YP   +5 more
openalex   +1 more source

Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection

, 2020
Ahmed AbdelKhalek, Mohamed N. Seleem
openalex   +2 more sources